Atopic Dermatitis Treatment in Thane & Mumbai
Atopic dermatitis (atopic eczema) is the most common chronic inflammatory skin disease worldwide — affecting up to 20% of children and 10% of adults in India. It is characterised by intense, unrelenting itch, recurrent skin inflammation, and a profoundly impaired skin barrier that makes the skin vulnerable to infections, irritants, and allergens. At KP Dermatology, Thane, Dr. Prratyush More (MBBS, DDVL — 14+ years of clinical experience) provides comprehensive, evidence-based atopic dermatitis management for patients of all ages — from infants to adults — tailored to every individual’s disease severity, triggers, and daily life.
Atopic dermatitis is far more than a skin condition — it is a systemic immune-mediated disease that disrupts sleep, impairs cognitive function, affects school and work performance, causes anxiety and depression, and — when inadequately treated — progressively worsens through the ‘atopic march’ to asthma and allergic rhinitis. Yet it remains enormously undertreated in India due to unfounded steroid fear, inadequate emollient use, and failure to identify personal triggers. Dr. More provides not just a prescription but a complete, individualised management programme.
Understanding Atopic Dermatitis — More Than Just Dry, Itchy Skin
Atopic dermatitis is caused by a complex interplay between genetic skin barrier dysfunction (particularly filaggrin protein mutations), Th2-skewed immune dysregulation (overproduction of IL-4, IL-13, IL-31 — the cytokines driving itch and inflammation), and environmental triggers. The impaired skin barrier allows allergens, irritants, and microbes to penetrate — triggering immune activation, inflammation, and the itch-scratch cycle that is the hallmark of atopic dermatitis. Repeated scratching further damages the barrier, creating a self-perpetuating inflammatory loop.
Atopic dermatitis is classified as mild (localised, occasional flares), moderate (more widespread, frequent flares, sleep disruption), or severe (extensive, continuous, severely impacts quality of life) — using validated scoring systems such as SCORAD and EASI. Treatment is stepwise — increasing from topical therapy through systemic immunosuppressants to targeted biologic therapies (dupilumab) for severe, refractory disease. Dr. Prratyush More correctly assesses your severity, identifies your specific triggers, and designs a treatment plan calibrated exactly to your disease burden.
Atopic Dermatitis Presentations We Treat
Dr. Prratyush More manages all ages and severities of atopic dermatitis at KP Dermatology, Thane — from neonatal eczema through to severe adult atopic dermatitis with systemic treatment needs.
Infantile Atopic Dermatitis (0–2 years)
Red, weeping, crusted eczema primarily on the cheeks and forehead — the classic infant presentation. Intense itch causes infant distress, sleep disruption, and parental exhaustion. Early, correct treatment may prevent the atopic march to asthma and hay fever.
Childhood Atopic Dermatitis (2–12 years)
Classic flexural eczema — inside elbows, behind knees, neck, wrists, and ankles. Lichenification (skin thickening from chronic scratching), pigmentary changes, and secondary bacterial infection are common. Interferes with school attendance and childhood activities.
Adult Atopic Dermatitis
Adult atopic dermatitis may persist from childhood or onset in adulthood. Typically affects the hands, face, neck, and flexures — often with prominent lichenification. Work-related exacerbation is common in occupational wet work.
Severe Atopic Dermatitis
Extensive, near-continuous, profoundly itchy eczema covering large body surface areas — causing constant sleep disruption, severe anxiety, depression, and dramatically impaired quality of life. Requires systemic or biologic therapy for adequate control.
Atopic Dermatitis with Secondary Infection
Staphylococcal superinfection of eczematous skin — producing golden crusting, weeping, and sudden severe flare. Viral superinfection with herpes simplex (eczema herpeticum) is a rare but serious emergency requiring immediate systemic antiviral treatment.
Atopic Hand Eczema
Eczema predominantly or exclusively affecting the hands — a severely debilitating occupational and functional condition. Caused by the combination of atopic skin barrier dysfunction and repeated wet work exposure. Requires barrier protection, emollient therapy, and often potent topical steroids.
Atopic Dermatitis with Molluscum Contagiosum
Molluscum contagiosum spreads rapidly in eczematous skin due to barrier impairment and local immune suppression. Each molluscum lesion triggers an eczematous ‘id reaction’ flare. Requires simultaneous eczema optimisation and molluscum treatment.
Atopic Dermatitis with Food Allergy (Paediatric)
In children under 2 years, food allergies (egg, cow’s milk, peanut, wheat, soy) can trigger or worsen atopic dermatitis. Formal allergy investigation (specific IgE testing) — not empirical dietary elimination — is required. Appropriate dietary management under dietetic guidance prevents nutritional compromise.
Refractory Adult Atopic Dermatitis
Adult atopic dermatitis inadequately controlled by optimised topical therapy — requiring assessment for systemic treatment (dupilumab biologic, cyclosporine, methotrexate, azathioprine). Dupilumab (anti-IL-4/IL-13 biologic) is the most effective and well-tolerated systemic option for severe atopic dermatitis.
At a Glance
| Consultation Duration | 30 – 45 Minutes |
| Scoring System | SCORAD / EASI used to grade severity |
| Investigations | Specific IgE, skin swab, patch testing when indicated |
| Condition Type | Chronic, Relapsing-Remitting |
| Treatment Range | Topical → Systemic → Biologic (dupilumab) |
| Suitable For | All Ages — Neonates through Adults |
The Atopic Dermatitis Treatment Process at KP Dermatology
Dr. Prratyush More provides a complete, stepwise, individually calibrated atopic dermatitis management programme — from emollient selection and correct steroid use through to systemic therapy assessment for severe disease.
01. Disease Severity Scoring & Personalised Assessment
Validated severity scoring (SCORAD/EASI) to objectively measure disease burden and guide treatment tier. Detailed history of triggers, previous treatments, emollient usage, atopic comorbidities (asthma, hay fever), family history, occupational factors, sleep impact, and quality of life (DLQI). Identification of personal trigger profile.
02. Emollient Optimisation — The Essential Foundation
The most impactful and most frequently under-prescribed component of atopic dermatitis treatment. Dr. More selects the most appropriate emollient formulation (cream, ointment, or lotion) for your skin type and prescribes it in sufficient quantity — 250–500g per week for an adult. Clear written instructions on application frequency (every 4–6 hours), correct technique, and the ‘3-minute rule’ (apply within 3 minutes of bathing to trap moisture).
03. Topical Corticosteroid Therapy
Correctly potency-matched topical steroids for each body site — mild (hydrocortisone) for face and flexures; moderate (triamcinolone) for body; potent (betamethasone, mometasone) for hands, feet, and lichenified skin. Clear written instructions: exact amount to apply (fingertip unit guidance), frequency, duration, and how to step down. Comprehensive steroid fear education — explaining what is safe vs what carries genuine risk.
04. Infection Management & Trigger Elimination
Topical or oral antibiotics for Staphylococcal superinfection. Urgent systemic antivirals (acyclovir) for eczema herpeticum — a dermatological emergency. House dust mite reduction measures, pet management, food allergy investigation (formal IgE testing, not empirical elimination), contact allergen patch testing, stress management, and occupational trigger modification.
05. Systemic Therapy Assessment
For moderate-to-severe atopic dermatitis inadequately controlled on optimised topical therapy — short courses of oral prednisolone for acute flares. Assessment for systemic immunosuppressants: dupilumab (biologic, most effective and safest for severe AD), cyclosporine, methotrexate, or azathioprine with appropriate baseline investigations, monitoring protocols, and referral coordination.
What to Expect with Atopic Dermatitis Treatment
With correctly prescribed, correctly applied, personalised atopic dermatitis management, the vast majority of patients at KP Dermatology achieve dramatic improvement — often the most significant improvement in their skin they have experienced, because so many patients have previously been undertreated.
Significant Itch Reduction
Rapid, dramatic reduction in pruritus — often within the first week of correctly applied topical steroids. Itch relief restores sleep, concentration, mood, and functional capacity immediately.
Skin Clearance & Texture Improvement
Progressive resolution of redness, scaling, weeping, crusting, and lichenification — with skin texture improving continuously as the inflammatory cycle is broken by correct, consistent emollient and anti-inflammatory therapy.
Sleep Restoration
Itch-related sleep disruption is the most debilitating consequence of atopic dermatitis. Effective disease control restores normal sleep — with downstream improvements in mood, energy, school performance, and quality of life.
Flare Frequency Reduction
With proactive emollient use, trigger avoidance, and a written flare action plan — flare frequency reduces substantially. Many patients go from weekly severe flares to manageable, infrequent episodes.
Infection Prevention
Optimised skin barrier function through consistent emollient use reduces Staphylococcal colonisation and secondary infection — the most common cause of sudden severe flares in atopic dermatitis.
Prevention of Atopic March
Early, effective atopic dermatitis treatment in infants and young children may reduce the risk of progression to asthma and allergic rhinitis — the sequential development of atopic conditions known as the atopic march.
Why Choose KP Dermatology for Atopic Dermatitis Treatment in Thane?
Dr. Prratyush More (MBBS, DDVL) provides comprehensive, evidence-based atopic dermatitis care at KP Dermatology, Vasant Vihar, Thane West — addressing every component of this complex disease with the personalised, structured approach that chronic inflammatory skin disease demands.
Objective Severity Assessment
SCORAD/EASI scoring at every consultation provides objective, reproducible measurement of disease severity — enabling evidence-based treatment decisions and clear documentation of treatment response over time.
Emollient Education — The Most Underutilised Tool
Most atopic dermatitis patients are dramatically under-emolliated. Dr. More prescribes emollients in clinically meaningful quantities, selects the right formulation, and teaches correct application — often producing the most significant improvement patients have ever seen.
Steroid Fear Resolution
Topical steroid phobia is the primary reason atopic dermatitis is undertreated in India. Dr. More provides clear, evidence-based education that distinguishes safe steroid use from genuinely risky use — empowering patients to treat their eczema effectively.
Trigger Identification & Management
Personalised trigger assessment — house dust mite, food allergens (in young children), contact allergens, stress, infections, occupational factors — with targeted, practical management strategies for each identified trigger.
Eczema Herpeticum Awareness
The rare but potentially life-threatening viral complication of atopic dermatitis. Dr. More educates all atopic dermatitis patients on warning signs and provides an emergency action plan, ensuring this is never missed.
Long-Term Partnership
Atopic dermatitis is a chronic condition requiring ongoing management. Dr. More provides structured follow-up, written flare action plans, proactive maintenance guidance, and accessibility for questions — a genuine long-term clinical partnership.
Frequently Asked Questions — Atopic Dermatitis
Common questions about atopic dermatitis causes, steroid safety, food triggers, adult-onset eczema, and biologic therapy — answered by Dr. Prratyush More.
Is atopic dermatitis the same as eczema?
Yes and no — atopic dermatitis is the most common form of eczema, but ‘eczema’ is a broader term that encompasses several different conditions including contact dermatitis, seborrheic dermatitis, discoid eczema, and pompholyx. Atopic dermatitis specifically refers to the immune-mediated, genetically predisposed chronic inflammatory condition strongly associated with asthma, hay fever, and food allergy — the ‘atopic triad.’ It follows a relapsing-remitting course throughout life in most patients. When someone says they have ‘eczema’, they most commonly mean atopic dermatitis — but accurate diagnosis by a dermatologist confirms the specific type.
My child has atopic eczema — does this mean they will develop asthma?
Atopic dermatitis, asthma, and allergic rhinitis (hay fever) are linked in the ‘atopic march’ — a sequential development of these conditions, typically beginning with atopic dermatitis in infancy and potentially progressing to asthma and hay fever in childhood. Not all children with atopic dermatitis develop asthma — the risk is highest in children with severe atopic dermatitis, early sensitisation to aeroallergens, and family history of asthma. Early, effective atopic dermatitis treatment may reduce the risk of the atopic march — one of the compelling reasons to treat infant eczema promptly and thoroughly.
Can adults develop atopic dermatitis for the first time?
Yes — while atopic dermatitis most commonly begins in infancy or childhood, adult-onset atopic dermatitis is increasingly recognised and may affect up to 3% of adults. It can present at any age, with or without previous history of eczema, asthma, or hay fever. Adult-onset atopic dermatitis is often more chronic and persistent than childhood disease and may require systemic therapy more frequently. It should be distinguished from other forms of adult eczema (contact dermatitis, seborrheic dermatitis) by appropriate clinical assessment.
What is dupilumab and do I need it for my eczema?
Dupilumab (Dupixent) is a biologic medication — a monoclonal antibody that specifically targets the IL-4/IL-13 signalling pathway that drives atopic dermatitis inflammation. It is a subcutaneous injection given every 2 weeks, and is currently the most effective and best-tolerated systemic treatment for moderate-to-severe atopic dermatitis. It does not cause the organ toxicity (kidney, liver, bone marrow) associated with traditional immunosuppressants. Dupilumab is considered when atopic dermatitis is inadequately controlled by optimised topical therapy and is causing significant quality of life impairment. Dr. More will assess your eligibility and facilitate referral or prescribing of dupilumab when clinically appropriate.
Is my child's food the cause of their eczema? Should I put them on an exclusion diet?
Food allergy is a genuine trigger for atopic dermatitis in children under 2 years — particularly egg and cow’s milk allergy — and should be formally investigated (specific IgE testing and skin prick testing) when clinically suspected. However, indiscriminate exclusion diets (removing dairy, gluten, eggs without investigation) in older children are not recommended — they are nutritionally restrictive, distressing for children and families, and rarely produce the expected improvement because food allergy becomes less prevalent as a trigger with increasing age. Dr. More will guide you on evidence-based allergy investigation only where clinically indicated — never empirical blanket elimination.
Transform Your Skin & Your Quality of Life — Book Today
Book your consultation for atopic dermatitis treatment in Thane at KP Dermatology. Dr. Prratyush More (MBBS, DDVL) will objectively assess your disease severity, identify your personal triggers, prescribe the correct emollient and anti-inflammatory therapy, and provide a comprehensive, written management plan — giving you the most effective, personalised atopic dermatitis care available in Thane.
📞 +91-93724 27275 | 📍 KP Dermatology, Vasant Vihar, Thane West – 400610